Dr. Richard Todd Weisenburger, D.O. Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 145 Medical Park Lane, Suite J, Murphy, NC 28906 Phone: 828-837-3223 Fax: 828-837-7706 |
News Archive
Freezing kidney tumors - using a safe minimally invasive interventional radiology treatment that kills the cancer 100 percent effectively without surgery - should be the gold standard or first treatment option for all individuals with tumors that are 4 centimeters in size or smaller.
Monash University researchers have found an important safety mechanism in the immune system that may malfunction in people with autoimmune diseases, such as Multiple Sclerosis, potentially paving the way for innovative treatments.
A new study released by Geisinger Health System researchers and appearing in the journal Neuropsychiatric Disease and Treatment reconfirms specific genetic risks associated with post-traumatic stress disorder (PTSD) and hopes to identify better screening and treatment options for the condition.
Colorectal cancer screening rates remain too low, with about one in three adults (ages 50 to 75 years) not being tested for colorectal cancer, according to a new Vital Signs report from the Centers for Disease Control and Prevention.
Boston Scientific Corporation today announced the start of patient enrollment in the EVOLVE clinical trial, which is designed to assess the safety and performance of its fourth-generation SYNERGYâ„¢ Coronary Stent. The first patient was enrolled by Ian Meredith, M.B.B.S., Ph.D., Professor and Director of MonashHeart, at Monash Medical Centre in Melbourne, Australia.
› Verified 6 days ago